中国分子确诊的墨西哥裸盖菇中毒病例系列:动态心肌损伤与多变幻觉潜伏期
该病例系列报告中国成都4例误食野生蘑菇(后经分子确诊为墨西哥裸盖菇)的中毒表现。摄入量16-90 g,前驱症状(如头晕)在5-20分钟内出现,幻觉发作时间差异大(10-180分钟)。所有患者均出现高血压(收缩压>150 mmHg),其中1例在摄入后4小时血压迅速升至182/110 mmHg,伴心肌损伤证据(肌钙蛋白T峰值188.70 pg/mL,参考范围<14 pg/mL)及一过性轻度骨骼肌受累(肌红蛋白峰值127.3 ng/mL,第2天恢复正常)。经洗胃、静脉雷尼替丁和液体治疗等支持治疗后均完全康复,无后遗症。作者认为未来裸盖菇素临床研究应优先筛查心血管合并症并对高危患者实施心脏监测。
要点
- 4例患者误食16-90 g野生蘑菇(误认为可食用种,后分子确诊为墨西哥裸盖菇),前驱症状如头晕在5-20分钟内出现。
- 幻觉发作潜伏期差异大(10-180分钟),所有患者均出现高血压(收缩压>150 mmHg)。
- 1例在摄入后4小时血压迅速升至182/110 mmHg,伴心肌损伤(肌钙蛋白T峰值188.70 pg/mL,参考范围<14 pg/mL)及一过性肌红蛋白升高(峰值127.3 ng/mL,第2天正常)。
- 经洗胃、静脉雷尼替丁和液体治疗等支持治疗后全部完全康复,无后遗症。
- 作者认为未来裸盖菇素研究应优先筛查心血管合并症并对高危患者实施心脏监测。
适用人群与场景
- 摄入野生蘑菇(误认为可食用种,后分子确诊为墨西哥裸盖菇)的4例患者,摄入量16-90 g。
处置流程与药物剂量
- 支持治疗:洗胃、静脉雷尼替丁和液体治疗,所有患者完全康复无后遗症。
红旗征与不能漏的情况
- 摄入后4小时血压迅速升至182/110 mmHg,伴心肌损伤证据(肌钙蛋白T峰值188.70 pg/mL,参考范围<14 pg/mL)。
- 所有患者出现高血压(收缩压>150 mmHg)。
- 一过性轻度骨骼肌受累(肌红蛋白峰值127.3 ng/mL,第2天恢复正常)。
研究设计与关键结果
- 病例系列:4例患者摄入16-90 g野生蘑菇(误认为可食用种,后分子确诊为墨西哥裸盖菇),前驱症状(如头晕)在5-20分钟内出现,幻觉发作时间10-180分钟。
- 所有患者出现高血压(收缩压>150 mmHg),1例在摄入后4小时血压迅速升至182/110 mmHg,伴心肌损伤(肌钙蛋白T峰值188.70 pg/mL,参考范围<14 pg/mL)及一过性轻度骨骼肌受累(肌红蛋白峰值127.3 ng/mL,第2天恢复正常)。
- 经洗胃、静脉雷尼替丁和液体治疗等支持治疗后全部完全康复,无后遗症。
证据类型、等级与局限
- 证据类型:病例系列(4例),来自中国成都。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为未来裸盖菇素临床研究应优先筛查心血管合并症并对高危患者实施心脏监测。
- 作者认为公共卫生教育应强调传统形态学鉴定方法和民间毒性测试均缺乏科学依据,必须倡导避免采食野生蘑菇,这是最可靠的预防策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Psychoactive Psilocybe spp. mushrooms pose significant public health risks. We report a cluster of Psilocybe keralensis poisonings in Chengdu, China, highlighting its unique clinical features and cardiovascular complications.
CASE SERIES: Four patients ingested 16-90 g of wild mushrooms (misidentified as an edible species, but later molecularly confirmed as Psilocybe keralensis). Prodromal symptoms (e.g., dizziness) emerged within 5-20 min, but the onset of hallucinations varied widely (10-180 min). All patients developed hypertension (systolic blood pressure >150 mmHg), with one patient exhibiting rapid blood pressure elevation to 182/110 mmHg at 4 h post-ingestion, which was accompanied by evidence of myocardial injury (peak cardiac troponin T concentration 188.70 pg/mL [reference range <14 pg/mL]) and transient mild skeletal muscle involvement (peak myoglobin concentration 127.3 ng/mL, which normalized by day 2). Supportive treatment (gastric lavage, intravenous ranitidine, and fluid therapy) led to full recovery without sequelae.
DISCUSSION: We observed altered myocardial biomarkers following Psilocybe keralensis poisoning, which signals potential cardiovascular risks.
CONCLUSION: Future clinical research on psilocybin should prioritize cardiovascular comorbidity screening and implement cardiac monitoring for high-risk patients. We believe that public health education should emphasize that both traditional morphological identification methods and folk-based toxicity testing lack scientific basis; it must advocate avoidance of wild mushroom foraging, which is the most reliable prevention strategy.
参考来源
- He Z, Tang R, Feng M, et al. Dynamic myocardial injury and variable hallucination latency in Psilocybe keralensis poisoning: a molecularly confirmed case series from China. Clin Toxicol (Phila). 2025. PMID: 40948398. doi:10.1080/15563650.2025.2552438
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。